Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

J&J’s second-in-command to retire, alongside executive restructure

June 25, 2018 Medical Communications, Sales and Marketing J&J, JJ, Johnson & Johnson, pharma

Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson (pictured) has announced she is to retire from her role and the …
News

Roche’s Tecentriq combo extends life in untreated lung cancer

June 25, 2018 Research and Development, Sales and Marketing Cancer, Roche, lung cancer, pharma, tecentriq

Roche has unveiled new data on the efficacy of Tecentriq (atezolizumab) in combination with chemotherapy (carboplatin and etoposide) for the …
News

Top Ten most popular articles on Pharmafile.com this week

June 22, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

The sun is out in the UK, it’s Friday, and the July/August issue of Pharmafocus is going to print. And, …
News

NICE backs Sanofi’s new treatment for atopic dermatitis

June 22, 2018 Medical Communications, Sales and Marketing England, NICE, Sanofi, UK, atopic dermatitis, pharma

NICE has published a positive Final Appraisal Determination FAD recommending dupilumab, in combination with topical corticosteroids, for use on the …
News

FDA approves first continuous glucose monitoring system

June 22, 2018 Medical Communications, Sales and Marketing FDA, diabetes, pharma

The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people …
News

AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer

June 22, 2018 Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …
News

Roche’s Ocrevus cleared for NHS use in relapsing-remitting MS

June 22, 2018 Medical Communications, Sales and Marketing MS, NICE, UK, multiple sclerosis, pharma

Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended …
News

Purdue culls 350 positions, eradicates sales force

June 21, 2018 Medical Communications, Sales and Marketing Purdue Pharma, opioid crisis, opioids, pharma

Bowing to the pressure applied by external groups for the part it has played in the ongoing opioid crisis, Purdue …
News

Aquinnah Pharmaceuticals receives $3.4 million grant to advance ALS therapies

June 21, 2018 Research and Development, Sales and Marketing Aquinnah Pharmaceuticals, als, amyotrophic lateral sclerosis, pharma

Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders …
News

Facebook unveils new feature to battle opioid crisis

June 20, 2018 Medical Communications, Research and Development, Sales and Marketing FDA, Facebook, US, opioid crisis, opioids, pharma

Despite its highly-publicised transgressions recently, tech giant Facebook is looking to do the right thing by wading into the ongoing …
News

FDA rejects Valeant plaque psoriasis lotion over pharmacokinetic concerns

June 19, 2018 Manufacturing and Production, Sales and Marketing FDA, Valeant, pharma, psoriasis

Beleaguered pharma firm Valeant has come up against another bump in the road as its plaque psoriasis lotion Duobrii (halobetasol …
News

Roche buys out rest of Foundation Medicine for $2.4bn

June 19, 2018 Manufacturing and Production, Sales and Marketing Foundation Medicine, Roche, biotech, drugs, pharma, pharmaceutical

Roche has clearly seen significant potential in Foundation Medicine’s work in genomics to pay $2.4 billion to take complete ownership …
News

Dr Reddy’s just-approved opioid dependence generic blocked over US patent dispute

June 18, 2018 Sales and Marketing Dr Reddy's, FDA, Mylan, US, opioid crisis, opioid dependence, opioids, suboxone

Dr Reddy’s Laboratories has taken two steps forward an one step back after its generic version of Suboxone Film (buprenorphine/naloxone) …
News

Maintaining control: The rising challenges of clinical data management

June 18, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

From breach scandals to GDPR, data is becoming a more prominent part of our everyday lives. This holds great potential …
Feature

HPV vaccine slashes rate of infection by 86% in UK

June 18, 2018 Medical Communications, Sales and Marketing HPV, biotech, drugs, pharma, pharmaceutical, vaccination

Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026